We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRTX
76
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$38.9M 0.28%
893,763
+20,000
+2% +$714K
DAR icon
77
Darling Ingredients
DAR
$9.62B
$37.6M 0.27%
721,078
-77,896
-10% -$4.87M
MNSO icon
78
MINISO
MNSO
$3.72B
$37.4M 0.27%
1,444,150
+1,237,150
+598% +$27.6M
SLB icon
79
SLB Ltd
SLB
$76.5B
$36.6M 0.26%
627,362
-47,506
-7% -$2.75M
KEYS icon
80
Keysight
KEYS
$53.6B
$36.4M 0.26%
274,950
+37,529
+16% +$5.56M
HLT icon
81
Hilton Worldwide
HLT
$75.3B
$35.9M 0.25%
238,869
+6,670
+3% +$1.01M
LNTH icon
82
Lantheus
LNTH
$7.03B
$35.7M 0.25%
514,461
+40,987
+9% +$3M
SYK icon
83
Stryker
SYK
$129B
$35.6M 0.25%
130,350
+4,582
+4% +$1.31M
VEEV icon
84
Veeva Systems
VEEV
$31.6B
$35.3M 0.25%
173,612
-1,892
-1% -$381K
WMS icon
85
Advanced Drainage Systems
WMS
$11B
$34.7M 0.25%
304,682
-83,338
-21% -$10.2M
KO icon
86
Coca-Cola
KO
$362B
$33.9M 0.24%
605,394
-394,278
-39% -$23.6M
BALL icon
87
Ball Corp
BALL
$17.2B
$33.1M 0.23%
665,819
+68,946
+12% +$3.76M
MU icon
88
Micron Technology
MU
$1.02T
$32.7M 0.23%
480,249
+110,779
+30% +$7.42M
BNY
89
Bank of New York Mellon
BNY
$107B
$32.7M 0.23%
765,978
+42,089
+6% +$1.88M
CL icon
90
Colgate-Palmolive
CL
$73.6B
$32M 0.23%
449,982
-31,473
-7% -$2.35M
PDD icon
91
Pinduoduo
PDD
$121B
$32M 0.23%
326,000
+49,200
+18% +$4.24M
VIPS icon
92
Vipshop
VIPS
$7.08B
$31.9M 0.23%
1,991,840
+20,000
+1% +$325K
LULU icon
93
lululemon athletica
LULU
$13.4B
$31.7M 0.22%
82,225
+1,611
+2% +$615K
ABBV icon
94
AbbVie
ABBV
$454B
$31.6M 0.22%
211,813
-3,372
-2% -$495K
SBUX icon
95
Starbucks
SBUX
$118B
$31.2M 0.22%
341,390
-10,126
-3% -$994K
MRVL icon
96
Marvell Technology
MRVL
$170B
$31.1M 0.22%
573,717
-124,141
-18% -$7.33M
XOM icon
97
ExxonMobil
XOM
$642B
$31M 0.22%
263,518
-57,030
-18% -$6.26M
BMRN icon
98
BioMarin Pharmaceuticals
BMRN
$11.6B
$30.8M 0.22%
348,549
-69,478
-17% -$6.18M
HUM icon
99
Humana
HUM
$45.8B
$30M 0.21%
61,748
+13,148
+27% +$6.18M
DXCM icon
100
DexCom
DXCM
$28.3B
$29.8M 0.21%
319,343
+248,729
+352% +$28M
2 3
4
5 6

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.